Skip to main content


In this Webinar, discover:

  • Subtle neurological deficits caused by TAVR
  • Discrepancies between clinical presentation versus neurological imaging
  • Stroke risk predictors, common misconceptions and the counterargument for cerebral embolic protection in low-risk patients
  • Evolving economics of TAVR and changes to reimbursement




David Z. Rose, MD

Associate Professor, Department of Neurology
Neurology Medical Director
USF Health, Tampa, FL


Hemal Gada, MD

Medical Director at Pinnacle Health
Cardiovascular Institute’s Structural Heart Program
UPMC Pinnacle, Harrisburg, PA

Full Replay

Watch the full cerebral embolic protection webinar replay here, or jump to specific webinar chapters by clicking on any of the videos below.
Stroke Risk Predictors & Perspectives



Watch by Chapter

Stroke Risk Predictors & Perspectives
Chapter 1:
TAVR-Related Stroke Risk Predictors
What causes ischemic stroke, and what are its impacts? Neurologist Dr. David Rose discusses known direct and indirect causes and impacts of stroke, stroke rates in contemporary TAVR (and SAVR arms) clinical trials, and stroke signs & symptoms that you should watch out for.
Stroke Risk Predictors & Perspectives
Chapter 2:
Why Subtle Neurological Deficits Matter
Neurologist Dr. David Rose reviews MRI brain scans to discover overt (clinical) neurological events as well as Silent Brain Infarcts (SBIs). See how to assess long-term patient outcomes associated with the subtle neurological deficits associated with TAVR, and learn how to advocate for increasingly younger patients with low surgical risk. 
Stroke Risk Predictors & Perspectives
Chapter 3:
The Impact of Stroke

Does stroke increase mortality in hospitalized patients post-TAVR? Does it affect patient Length of Stay? Neurologist Dr. David Rose discusses why stroke risk in TAVR may not be impacted by the experience of a TAVR team.
Stroke Risk Predictors & Perspectives
Chapter 4:
TAVR Costs in an Evolving Landscape

With the commercialization of low-risk TAVR treatments, new treatment centers, and increasing TAVR volumes, the TAVR landscape is evolving. Hear Medical Director at UMPC Pinnacle Health and implanting Interventional Cardiologist, Dr. Hemal Gada, discuss the implications of a changing landscape and clinical data considerations around TAVR and TAVR-related stroke.
Stroke Risk Predictors & Perspectives
Chapter 5:
SENTINEL Technology and Clinical Data

Dr. Gada provides an overview of SENTINEL technology, clinical data, and limitations -- from SENTINEL's performance in its IDE trial to stroke reduction rates demonstrated across global contemporary studies.
Stroke Risk Predictors & Perspectives
Chapter 6:
The Economics of Stroke and Cerebral Embolic Protection
TAVR Implanter Dr. Hemal Gada breaks down the economics of stroke in TAVR and highlights different perspectives on the cost of cerebral embolic protection. Understand what’s happening to reimbursement in TAVR—and what reimbursement for stroke-protecting TAVR devices may look like for your center and others going forward.
Stroke Risk Predictors & Perspectives
Chapter 7:
Q&A with Drs. Hemal Gada & David Rose
In this recorded interactive Q&A session from the SENTINEL Therapy Awareness webinar, Drs. Hemal Gada and David Rose answer the questions on device deployment, patient selection, and the PROTECTED TAVR clinical trial. 





Instructions for Use  |  Ordering Information